Stifel Nicolaus upgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a hold rating to a buy rating in a report published on Thursday morning, Ratings reports. The firm currently has ...

Viavi Solutions (NASDAQ:VIAV – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Stifel ...

Stifel Nicolaus analyst Matthew Smith, CFA maintained a Buy rating on Altria Group (MO – Research Report) today and set a price target of ...

Stifel Nicolaus analyst Bradley Canino maintained a Buy rating on Syndax Pharmaceuticals (SNDX – Research Report) today and set a price target ...

Stifel analysts adjusted their outlook on Intel stock (NASDAQ:INTC), lowering the price target to $21.00 from the previous $25.00, while keeping a Hold rating on the shares. The revision follows Intel ...

The Corporation has granted the Co-Lead Agents an option to sell up to an additional 15% of the aggregate amount of the Offered Securities (the "Over-Allotment Option"), on the same terms and ...

Stifel chief executive Ron Kruszewski said surging markets have forced firms to be particularly choosy about which advisors ...

Reports Q4 revenue $1.364B, consensus $1.28B. Ronald J. Kruszewski, Chairman and Chief Executive Officer, said “Stifel generated record net ...